Freshpet stock slides as Fed minutes loom in thin year-end trade (FRPT)
30 December 2025
1 min read

Freshpet stock slides as Fed minutes loom in thin year-end trade (FRPT)

NEW YORK, December 30, 2025, 1:59 PM ET — Regular session

  • Freshpet shares fell 3.5% to $60.84 in afternoon trading, sharply underperforming a flat broader market.
  • Investors are bracing for Federal Reserve meeting minutes due at 2 p.m. ET, with year-end volumes still thin.
  • Traders are watching the next earnings update for demand and margin signals.

Freshpet, Inc. shares were down 3.5% at $60.84 by 1:59 p.m. ET on Tuesday, extending a choppy stretch for the pet food maker’s stock.

The slide stood out against an otherwise muted session, a reminder that thinner year-end liquidity can exaggerate moves in single names.

The stock’s drop also comes hours before the Federal Reserve releases minutes from its December policy meeting at 2 p.m. ET — a closely watched readout that can shift rate expectations and, by extension, valuations for stocks priced on future growth. https://www.reuters.com/business/final-fed-minutes-2025-shed-light-policy-divisions-2025-12-30/

U.S. stocks traded in a tight range, with gains in communication services offset by weakness in tech and financials, Reuters reported. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” Mark Hackett, chief market strategist at Nationwide, said. https://www.reuters.com/business/us-stock-futures-stabilize-after-tech-led-dip-halts-year-end-rally-2025-12-30/

Freshpet makes fresh, refrigerated pet food sold through company-owned branded refrigerators placed in retail stores, including grocery and mass merchants. https://www.reuters.com/markets/companies/FRPT.O/

The consumer staples sector was little changed, with the Consumer Staples Select Sector SPDR Fund down about 0.1%. Shares of General Mills and J.M. Smucker — both owners of major pet food brands — were each down less than 1% in afternoon trading.

Freshpet traded between $62.79 and $60.84 on the day, hitting the session low as the selloff accelerated, market data showed.

Freshpet has not posted a new SEC filing since a December 12 Form 8-K, according to the filing on the SEC’s EDGAR system. 1

With no fresh company-specific disclosures on Tuesday, traders largely treated the name as part of the day’s broader positioning and rates-driven tape.

The next big checkpoint is the company’s next earnings report, which MarketBeat estimates for February 19, 2026, though the company has not confirmed the date. 2

Investors will be looking for signals on demand trends, retail distribution growth, and profit margins, as well as any update on spending levels and cash generation.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy
Previous Story

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook
Next Story

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Go toTop